All News

The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.

Researchers believe the progression of allergies begins with eczema in infancy before progressing to food allergies, asthma, and hay fever later in childhood.

Successfully implementing HIV and hepatitis C testing at drug detoxification centers could help identify and link patients to care, but would require that the test results are available to nearby health care facilities.

Although the use of preexposure prophylaxis against HIV has increased across the United States in recent years, the rise in costs across the health care system has yet to be fully catalogued.

Pharmacy Times® interviewed Steven Lucio, vice president of Pharmacy Solutions at Vizient, on the ways that the COVID-19 pandemic has affected hospital spending this year, which is projected to result in increased drug spending for 2021.

The emergency use of drugs to shorten hospitalization and prolong time for COVID-19 vaccine research and development will serve as a critical temporary buffer for an efficient vaccine to combat SARS-CoV-2.

The terms of participation in the phase 2 round of the Provider Relief Fund created an unintended exclusion for pharmacies that primarily serve Medicaid/Children’s Health Insurance Program patients.

Iron deposits may be the cause of cognitive decline in those who have high alcohol consumption, which vitamin B1 may help prevent.

Mindfulness training may hold the key to reducing the risk of cardiovascular disease, which is rapidly becoming the leading cause of death worldwide.

Although antiretroviral therapy is an important option for patients with HIV, the viral reservoir has been a major obstacle for researchers looking to effectively cure the disease.

Research suggests that those with progressive multiple sclerosis may have adjusted more effectively to lockdown conditions.

Researchers at the Rensselaer Polytechnic Institute recently published a study on the use of the FDA-approved anticoagulant heparin in patients with COVID-19.

What drink in the 19th century was created by infusing coca leaves into a bottle of Bordeaux?

Top news of the week from Pharmacy Times®.

Racial and economic disparities are especially pronounced among patients on Medicare, study shows.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.

Post-menopausal women are at a heightened risk of Alzheimer disease.

The pandemic is exacerbating many of the conditions that contribute to relapse or people using substances just to cope, including unemployment, stress, fear, anxiety, and isolation.

The results of the study found that adults who experienced 4 common symptoms of anxiety and depression have upwards of 2 times greater risk of delaying medical care or not receiving needed non-COVID-19 medical care amidst the pandemic.

In a phase 3 clinical trial, oral paclitaxel was found to be just as effective intravenous paclitaxel in metastatic breast cancer.

STACK is the industry's only Pharmacy Information Management Platform.

The action is part of a growing movement to expand the ability of pharmacists and pharmacy staff to meet the needs of patients during the COVID-19 pandemic.

Pharmacy Times spoke with Russell Procopio, executive vice president of Long-Term Care Pharmacy, about a new study regarding long-term care outcomes and cost.

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.

A simple test may be a low-cost way of identifying patients at-risk for type 2 diabetes.

Mailing educational materials to patients with atrial fibrillation and their clinicians did not increase the use of stroke prevention drugs.

With OTC melatonin readily available and its product awareness high among consumers, many pharmacists may be interested in learning more about its safety and efficacy.